Us Bancorp \De\ Spectrum Pharmaceuticals Inc Transaction History

Us Bancorp \De\

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	BUY	$0.7 - $1.4 $272,399 - $544,798	389,142 New	389,142 $304,000
Q4 2021 Feb 11, 2022	SELL	$1.27 - $2.42 $793 - $1,512	-625 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$2.15 - $3.82 $829 - $1,474	-386 Reduced 38.18%	625 $1,000
Q2 2021 Aug 05, 2021	BUY	$2.89 - $4.45 $2,921 - $4,498	1,011 New	1,011 $4,000
Q2 2020 Aug 07, 2020	SELL	$2.11 - $3.38 $2,105 - $3,373	-998 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$1.83 - $3.45 $1,718 - $3,239	939 Added 1591.53%	998 $2,000
Q4 2019 Feb 04, 2020	SELL	$3.5 - $10.35 $847 - $2,504	-242 Reduced 80.4%	59 $0
Q3 2019 Nov 08, 2019	BUY	$7.03 - $9.7 $21 - $29	3 Added 1.01%	301 $2,000
Q2 2019 Aug 13, 2019	BUY	$7.36 - $11.26 $1,295 - $1,981	176 Added 144.26%	298 $3,000
Q1 2019 May 08, 2019	SELL	$9.08 - $11.84 $10,451 - $13,627	-1,151 Reduced 90.42%	122 $1,000
Q4 2018 Feb 13, 2019	SELL	$6.39 - $16.99 $3,431 - $9,123	-537 Reduced 29.67%	1,273 $11,000
Q3 2018 Nov 01, 2018	SELL	$16.52 - $24.82 $22,318 - $33,531	-1,351 Reduced 42.74%	1,810 $30,000
Q2 2018 Aug 08, 2018	BUY	$14.31 - $21.75 $11,448 - $17,400	800 Added 33.88%	3,161 $66,000
Q1 2018 May 08, 2018	BUY	$16.09 - $23.07 $37,988 - $54,468	2,361 New	2,361 $38,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.